BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6060425)

  • 1. [A test of rapid inhibition of the pituitary-adrenal axis (single dose of dexamethasone)].
    Bricaire H; Leprat J; Laudat P; Luxton JP; Milgrom E; Laurent D
    Ann Endocrinol (Paris); 1967; 28(1):65-70. PubMed ID: 6060425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Paradoxical response to dexamethasone. A contribution to the differential diagnosis of adrenal hyperfunction?].
    Serrera Contreras JL; Molina Miró J; Astorga Jiménez R
    Rev Iber Endocrinol; 1974; 21(122):127-48. PubMed ID: 4364544
    [No Abstract]   [Full Text] [Related]  

  • 3. Cushing's syndrome: use of lysine vasopressin to distinguish overproduction of corticotrophin by pituitary from other causes of adrenal cortical hyperfunction.
    Webb-Peploe MM; Spathis GS; Reed PI
    Lancet; 1967 Jan; 1(7483):195-7. PubMed ID: 4163130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional exploration of the adrenal cortex in basal and dynamic conditions in hypercorticism of the Cushing type].
    Minozzi M; Faggiano M; Salerno M; Lombardi G; Nunziata V
    Folia Endocrinol; 1968 Jun; 21(3):292-311. PubMed ID: 4304524
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of adrenal glucocorticoid function. Which tests are appropriate for screening?
    Hasinski S
    Postgrad Med; 1998 Jul; 104(1):61-4, 69-72. PubMed ID: 9676562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. II. Studies on the pituitary-adrenocortical suppression test].
    Sako T
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1016-24. PubMed ID: 4304528
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Bethge H; Bayer JM; Winkelmann W
    Acta Endocrinol (Copenh); 1969 Jan; 60(1):47-59. PubMed ID: 4308289
    [No Abstract]   [Full Text] [Related]  

  • 8. The diagnosis of hypercortisolism. Biochemical criteria differentiating patients from lean and obese normal subjects and from females on oral contraceptives.
    Streeten DH; Stevenson CT; Dalakos TG; Nicholas JJ; Dennick LG; Fellerman H
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1191-211. PubMed ID: 5808526
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple twenty-four hour test to evaluate hypothalamus-pituitary-adrenal cortical function.
    Hawley WD; de Balbian Verster F; de Rodriquez GV; Schally AV; Bowers CY
    J Clin Endocrinol Metab; 1968 Apr; 28(4):558-66. PubMed ID: 4296165
    [No Abstract]   [Full Text] [Related]  

  • 10. Cushing's syndrome associated with a "corticotrophin"-producing bronchial neoplasm neoplasm (results of corticotrophin assays and of pituitary-adrenal function tests).
    Landon J; James VH; Peart WS
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):321-32. PubMed ID: 4293813
    [No Abstract]   [Full Text] [Related]  

  • 11. A FOUR-DAY CORTICOTROPHIN-SUPPRESSION TEST. STUDIES IN CUSHING'S SYNDROME AND IN NON CUSHING SUBJECTS WITH RELATED SYMPTOMS.
    ERNEST I
    Acta Endocrinol (Copenh); 1965 Jan; 48():147-62. PubMed ID: 14254767
    [No Abstract]   [Full Text] [Related]  

  • 12. Corticotropin-releasing factor, a new aid in the diagnosis of pituitary-adrenal disorders?
    Hermus AR; Pieters GF; Smals AG; Kloppenborg PW
    Neth J Med; 1985; 28(1):2-5. PubMed ID: 2983245
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of modified stimulation test in the diagnosis of adrenal cortex diseases].
    Konopka P; Morawek A; Religa Z
    Pol Arch Med Wewn; 1969 Jul; 43(1):1025-34. PubMed ID: 4310037
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid dexamethasone suppression test for Cushing's syndrome.
    Tucci JR; Jagger PI; Lauler DP; Thorn GW
    JAMA; 1967 Feb; 199(6):379-82. PubMed ID: 5334596
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic tests for children who are referred for the investigation of Cushing syndrome.
    Batista DL; Riar J; Keil M; Stratakis CA
    Pediatrics; 2007 Sep; 120(3):e575-86. PubMed ID: 17698579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
    BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
    J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
    [No Abstract]   [Full Text] [Related]  

  • 17. Cushing's syndrome: diagnosis and surgical management.
    Pridgen WR; Tipton BK; Pitcock JA
    South Med J; 1973 Mar; 66(3):313-6. PubMed ID: 4691009
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of urinary cortisol determinations by competetive protein-binding radioassay.
    Murphy BE
    J Clin Endocrinol Metab; 1968 Mar; 28(3):343-8. PubMed ID: 4296070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
    Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
    Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The single dexamethasone suppression test in the diagnosis of Cushing's syndrome].
    Schjoth A; Toien I
    Nord Med; 1968 Feb; 79(8):237-42. PubMed ID: 5657614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.